C. Cooper

First name

C.

Last name

Cooper

van Staa, T. P., Leufkens, H. G., Abenhaim, L., Begaud, B., Zhang, B., & Cooper, C. (2000). Use of oral corticosteroids in the United Kingdom. Qjm.

View

van Staa, T. P., Wegman, S., de Vries, F., Leufkens, B., & Cooper, C. (2001). Use of statins and risk of fractures. Jama.

View

van Staa, T. P., Dennison, E. M., Leufkens, H. G., & Cooper, C. (2001). Epidemiology of fractures in England and Wales. Bone.

View

van Staa, T. P., Abenhaim, L., Cooper, C., Zhang, B., & Leufkens, H. G. (2001). Public health impact of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol.

View

van Staa, T. P., Leufkens, H. G., & Cooper, C. (2001). Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res. http://doi.org/10.1359/jbmr.2001.16.3.581

View

van Staa, T. P., Leufkens, H. G., & Cooper, C. (2002). Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int. http://doi.org/10.1007/s001980200084

View

van Staa, T. P., Selby, P., Leufkens, H. G., Lyles, K., Sprafka, J. M., & Cooper, C. (2002). Incidence and natural history of Paget\textquoterights disease of bone in England and Wales. J Bone Miner Res. http://doi.org/10.1359/jbmr.2002.17.3.465

View

van Staa, T. P., Leufkens, H. G., & Cooper, C. (2002). Utility of medical and drug history in fracture risk prediction among men and women. Bone.

View

van Staa, T. P., Boulton, F., Cooper, C., Hagenbeek, A., Inskip, H., & Leufkens, H. G. (2003). Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. Am J Hematol. http://doi.org/10.1002/ajh.10295

View

Souverein, P. C., van Staa, T. P., Egberts, A. C., De la Rosette, J. J., Cooper, C., & Leufkens, H. G. (2003). Use of alpha-blockers and the risk of hip/femur fractures. J Intern Med.

View